drugset / Trial / NCT02306031

Topical Diclofenac on Macular Thickness After Phacoemulsification

NCT02306031

Phase 2 Unknown 108 enrolled Shahid Beheshti University of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

Eyes of 108 diabetic patients have underwent phacoemulsification and intraocular lens implantation surgery have enrolled. Fifty four eyes have received the conventional postoperative care with steroid drop, whereas the other group (54 eyes) have given a preoperative diclofenac drop four times daily in addition to steroid drop and continued six weeks after surgery. All patients have evaluated by Optical coherence tomography (OCT) preoperatively and days 1, 30, and 90.The outcome measures including best corrected visual acuity (BCVA) and OCT findings were compared in and between both groups.

Timeline

Start
2013-06
Primary completion
2014-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 0.1 % Topical

Indications